Agfa HealthCare Highlights "Innovating Visual Healthcare" at RSNA 2015

Agfa HealthCareAgfa HealthCare will demonstrate the company's focus on "Innovating Visual Healthcare" at RSNA 2015, being held from November 29-December 4 in Chicago, Illinois (USA). Building on its 100+ years of experience, Agfa HealthCare develops innovations that offer the ease of use customers need to maximize the potential of the solutions, with designs that keep the clinical user and patient in mind. At RSNA 2015, Agfa HealthCare will show how this focus has resulted in concrete achievements, including a single platform for IT as well as a single platform for Imaging.

IT: launching a new Enterprise Imaging Platform
Agfa HealthCare's completely consolidated Enterprise Imaging platform takes a whole new approach to solving provider challenges within Image management from acquisition and diagnostics through distribution. The solution offers a flexible workflow engine, a blend of structured and voice recognition reporting, advanced image processing and integration of clinical information, all in one, modular sophisticated platform. It simplifies secure access to a single, comprehensive patient imaging record, empowers physicians to make informed decisions through multi-specialty collaboration, and addresses many different process workflows to help improve the delivery of patient care and streamlines costs. The care-centric platform is highly scalable and intuitive, maximizing user productivity and clinical efficiency, while keeping cost of ownership for IT and management exceptionally low.

Imaging: next generation MUSICA platform
With each decade, Agfa HealthCare's MUSICA software has been taking image processing to the next level. A truly intelligent and independent solution, it provides consistently high image quality to support diagnosis, while saving both time and effort. All of Agfa HealthCare's computed radiography (CR) and direct radiography (DR) solutions are supported by MUSICA, offering time saving, ease of use and excellent output images, regardless of dose, collimation, body part or patient position. Enhancements to the latest generation MUSICA include no need to adjust window level and a balanced presentation of different tissue structures for comfortable reading.

Being an essential part of Agfa HealthCare's Fast Forward strategy, the MUSICA platform also supports the ALARA (As Low As Reasonably Achievable) principle in managing patient radiation dose. Agfa HealthCare is committed to playing a part in delivering solutions that provide diagnostic image quality at the lowest dose reasonably achievable, through state-of-the-art technologies that include cesium-based digital radiography[1] and dose monitoring solutions.

In the spotlight at RSNA 2015
Next to the new Enterprise Imaging innovative Platform, the new DR 600, a works in progress in the U.S. and Canada*, fully automated, state-of-the-art, multi-detector, high-productivity and high-throughput digital X-ray room and Mobile DR with FreeView technology, which makes navigating with the highly maneuverable DR Mobile even easier and safer, are in the spotlight at the show.

"This year marks the 100th anniversary of RSNA, and it is looking forward to the next century with the theme 'Innovation is the key to our future'," says Luc Thijs, President of Agfa HealthCare. "This theme fits perfectly with Agfa HealthCare's own identity as a forward-focused company whose mission embodies innovation: we use our expertise and understanding of the healthcare industry to design innovations that always consider the needs of the clinical user and patient, and that remain easy to use. By developing one platform for IT and one platform for Imaging we are doing exactly that: simplifying even as we enhance performance."

Visit us at RSNA, booth# 1315, South Hall, November 29-December 4, McCormick Place, Chicago, IL, USA.

* DR 600 is a works in progress with regulatory clearances pending in the U.S. and Canada.
1. Testing with board-certified radiologists has determined that Cesium Bromide (CR) and Cesium Iodide (DR) Detectors, when used with MUSICA image processing, can provide dose reductions between 50 to 60%, compared to traditional Barium Fluoro Bromide CR systems. Contact Agfa HealthCare for more details.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,865 million euro in 2013.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2013 were 1,160 million euro.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...